Advisor Group Holdings, Inc. Arcturus Therapeutics Holdings Inc. Transaction History

Advisor Group Holdings, Inc.

  • $42.2 Billion
  • Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 669 shares of ARCT stock, worth $12,028. This represents 0.0% of its overall portfolio holdings.

Number of Shares
669
Previous 670 0.15%
Holding current value
$12,028
Previous $16,000 6.25%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$18.08 - $25.38 $18 - $25
-1 Reduced 0.15%
669 $15,000
Q2 2024

Aug 13, 2024
SELL
$24.35 - $44.39 $5,064 - $9,233
-208 Reduced 23.69%
670 $16,000
Q1 2024

May 10, 2024
SELL
$31.23 - $42.99 $2,935 - $4,041
-94 Reduced 9.67%
878 $29,000
Q4 2023

Feb 12, 2024
SELL
$17.71 - $32.97 $13,087 - $24,364
-739 Reduced 43.19%
972 $30,000
Q3 2023

Nov 13, 2023
BUY
$25.44 - $37.35 $1,043 - $1,531
41 Added 2.46%
1,711 $43,000
Q2 2023

Aug 10, 2023
SELL
$23.94 - $32.36 $3,255 - $4,400
-136 Reduced 7.53%
1,670 $47,000
Q1 2023

May 12, 2023
SELL
$14.72 - $23.97 $2,576 - $4,194
-175 Reduced 8.83%
1,806 $43,000
Q4 2022

Feb 10, 2023
SELL
$14.14 - $23.06 $4,694 - $7,655
-332 Reduced 14.35%
1,981 $33,000
Q3 2022

Nov 14, 2022
SELL
$13.05 - $22.13 $1,800 - $3,053
-138 Reduced 5.63%
2,313 $33,000
Q2 2022

Aug 10, 2022
SELL
$12.26 - $31.17 $858 - $2,181
-70 Reduced 2.78%
2,451 $37,000
Q1 2022

May 04, 2022
SELL
$17.64 - $39.57 $26,054 - $58,444
-1,477 Reduced 36.94%
2,521 $68,000
Q3 2021

Nov 05, 2021
SELL
$27.88 - $58.25 $13,577 - $28,367
-487 Reduced 10.86%
3,998 $191,000
Q2 2021

Aug 02, 2021
SELL
$25.79 - $42.11 $537,618 - $877,825
-20,846 Reduced 82.29%
4,485 $151,000
Q1 2021

May 13, 2021
BUY
$38.75 - $86.92 $794,685 - $1.78 Million
20,508 Added 425.21%
25,331 $1.05 Million
Q4 2020

Feb 10, 2021
BUY
$34.61 - $123.66 $62,747 - $224,195
1,813 Added 60.23%
4,823 $209,000
Q3 2020

Nov 12, 2020
BUY
$37.49 - $63.19 $47,349 - $79,808
1,263 Added 72.3%
3,010 $129,000
Q2 2020

Aug 14, 2020
BUY
$12.66 - $58.27 $14,521 - $66,835
1,147 Added 191.17%
1,747 $82,000
Q1 2020

May 18, 2020
BUY
$9.31 - $18.26 $5,586 - $10,956
600 New
600 $8,000

Others Institutions Holding ARCT

# of Institutions
178
Shares Held
25.6M
Call Options Held
195K
Put Options Held
133K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $478M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email